Analysts Set Expectations for Privia Health Group, Inc.’s Q4 2023 Earnings (NASDAQ:PRVA)

Privia Health Group, Inc. (NASDAQ:PRVAGet Rating) – Stock analysts at William Blair issued their Q4 2023 earnings per share estimates for shares of Privia Health Group in a research note issued on Thursday, May 12th. William Blair analyst R. Daniels forecasts that the company will post earnings of $0.16 per share for the quarter.

A number of other equities analysts also recently commented on the stock. Guggenheim assumed coverage on shares of Privia Health Group in a research note on Tuesday, March 29th. They issued a “buy” rating and a $35.00 price objective for the company. Bank of America began coverage on shares of Privia Health Group in a report on Tuesday, May 3rd. They issued a “buy” rating and a $27.00 price target on the stock. BTIG Research began coverage on shares of Privia Health Group in a report on Thursday, April 28th. They issued a “buy” rating and a $35.00 price target on the stock. Cowen raised shares of Privia Health Group from a “market perform” rating to an “outperform” rating and set a $35.00 price target on the stock in a report on Tuesday, February 22nd. Finally, SVB Leerink boosted their price objective on shares of Privia Health Group from $43.00 to $44.00 and gave the company an “outperform” rating in a report on Friday, March 25th. One equities research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $40.00.

NASDAQ PRVA traded up $1.73 during trading on Friday, hitting $22.45. The stock had a trading volume of 11,267 shares, compared to its average volume of 532,138. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.35 and a current ratio of 2.35. The stock has a market capitalization of $2.43 billion and a price-to-earnings ratio of -11.38. Privia Health Group has a one year low of $17.99 and a one year high of $50.77. The stock has a 50 day simple moving average of $24.96 and a 200 day simple moving average of $24.65.

Privia Health Group (NASDAQ:PRVAGet Rating) last issued its quarterly earnings data on Tuesday, March 22nd. The company reported ($0.12) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.17. The firm had revenue of $275.33 million during the quarter, compared to analyst estimates of $226.06 million. Privia Health Group had a negative return on equity of 54.01% and a negative net margin of 19.48%.

Institutional investors have recently modified their holdings of the business. Rockefeller Capital Management L.P. acquired a new stake in shares of Privia Health Group in the fourth quarter valued at about $25,000. First Horizon Advisors Inc. acquired a new stake in shares of Privia Health Group in the fourth quarter valued at about $26,000. FourThought Financial LLC acquired a new stake in shares of Privia Health Group in the third quarter valued at about $32,000. Gleason Group Inc. acquired a new stake in shares of Privia Health Group in the first quarter valued at about $57,000. Finally, Fifth Third Bancorp acquired a new position in Privia Health Group during the fourth quarter worth about $68,000. 63.77% of the stock is currently owned by institutional investors.

In other Privia Health Group news, EVP Thomas Bartrum sold 10,000 shares of the firm’s stock in a transaction on Wednesday, April 20th. The shares were sold at an average price of $27.93, for a total transaction of $279,300.00. Following the transaction, the executive vice president now directly owns 27,391 shares of the company’s stock, valued at approximately $765,030.63. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Parth Mehrotra sold 20,000 shares of the firm’s stock in a transaction on Wednesday, April 20th. The stock was sold at an average price of $27.93, for a total transaction of $558,600.00. Following the transaction, the chief operating officer now directly owns 97,391 shares in the company, valued at $2,720,130.63. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 90,000 shares of company stock worth $2,349,800. 57.60% of the stock is owned by company insiders.

About Privia Health Group (Get Rating)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Featured Articles

Earnings History and Estimates for Privia Health Group (NASDAQ:PRVA)

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.